Bone Marrow Senescence and the Microenvironment of Hematological Malignancies

被引:20
|
作者
Hellmich, Charlotte [1 ,2 ]
Moore, Jamie A. [1 ]
Bowles, Kristian M. [1 ,2 ]
Rushworth, Stuart A. [1 ]
机构
[1] Univ East Anglia, Norwich Med Sch, Norwich, Norfolk, England
[2] Norfolk & Norwich Univ Hosp NHS Trust, Dept Haematol, Norwich, Norfolk, England
来源
FRONTIERS IN ONCOLOGY | 2020年 / 10卷
基金
英国惠康基金;
关键词
senescence; cancer microenvironment; leukemia; p16INK4a; SASP; ACUTE MYELOID-LEUKEMIA; HEMATOPOIETIC STEM-CELLS; CLONAL HEMATOPOIESIS; CELLULAR SENESCENCE; MULTIPLE-MYELOMA; IN-VIVO; CANCER; AGE; PROMOTES; CLEARANCE;
D O I
10.3389/fonc.2020.00230
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Senescence is the irreversible arrest of cell proliferation that has now been shown to play an important role in both health and disease. With increasing age senescent cells accumulate throughout the body, including the bone marrow and this has been associated with a number of age-related pathologies including malignancies. It has been shown that the senescence associated secretory phenotype (SASP) creates a pro-tumoural environment that supports proliferation and survival of malignant cells. Understanding the role of senescent cells in tumor development better may help us to identify new treatment targets to impair tumor survival and reduce treatment resistance. In this review, we will specifically discuss the role of senescence in the aging bone marrow (BM) microenvironment. Many BM disorders are age-related diseases and highly dependent on the BM microenvironment. Despite advances in drug development the prognosis particularly for older patients remains poor and new treatment approaches are needed to improve outcomes for patients. In this review, we will focus on the relationship of senescence and hematological malignancies, how senescence promotes cancer development and how malignant cells induce senescence.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] BONE MARROW MICROENVIRONMENT AS A THERAPEUTIC TARGET IN HEMATOLOGICAL MALIGNANCIES: THE MYELOMA LESSON
    Giuliani, Nicola
    CYTOMETRY PART A, 2010, 77A (02) : 152 - 152
  • [2] MRI of bone marrow abnormalities in hematological malignancies
    Silva, Jose Roberto, Jr.
    Hayashi, Daichi
    Yonenaga, Takenori
    Fukuda, Kunihiko
    Genant, Harry K.
    Lin, Chieh
    Rahmouni, Alain
    Guermazi, Ali
    DIAGNOSTIC AND INTERVENTIONAL RADIOLOGY, 2013, 19 (05) : 393 - 399
  • [3] Targeting the bone marrow microenvironment in hematologic malignancies
    Dalton, WS
    Hazlehurst, L
    Shain, K
    Landowski, T
    Alsina, M
    SEMINARS IN HEMATOLOGY, 2004, 41 (02) : 1 - 5
  • [4] Bone marrow fibrosis: a prognostic scar in hematological malignancies
    Tadmor, Tamar
    Polliack, Aaron
    LEUKEMIA & LYMPHOMA, 2013, 54 (11) : 2349 - 2350
  • [5] Magnetic resonance imaging of the bone marrow in hematological malignancies
    Vande Berg, BC
    Lecouvet, FE
    Michaux, L
    Ferrant, A
    Maldague, B
    Malghem, J
    EUROPEAN RADIOLOGY, 1998, 8 (08) : 1335 - +
  • [6] AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN HEMATOLOGICAL MALIGNANCIES
    GORIN, NC
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1991, 14 : S5 - S14
  • [7] THE SIGNIFICANCE OF BONE-MARROW EVALUATION IN HEMATOLOGICAL MALIGNANCIES
    DOHNER, H
    EHRHARDT, R
    RADIOLOGE, 1992, 32 (10): : 481 - 484
  • [8] Magnetic resonance imaging of the bone marrow in hematological malignancies
    B. C. Vande Berg
    F. E. Lecouvet
    L. Michaux
    A. Ferrant
    B. Maldague
    J. Malghem
    European Radiology, 1998, 8 : 1335 - 1344
  • [9] AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN HEMATOLOGICAL MALIGNANCIES
    GORIN, NC
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1984, 20 (01): : 1 - 9
  • [10] ALLOGENEIC BONE-MARROW TRANSPLANTATION IN HEMATOLOGICAL MALIGNANCIES
    GAHRTON, G
    GRATWOHL, A
    ERNST, P
    HERMANS, J
    LYKLEMA, A
    ZWAAN, FE
    BONE MARROW TRANSPLANTATION, 1989, 4 : 4 - 6